International IP estate further strengthened for Feraccru

6 Sep 2017

Shield Therapeutics is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a composition of matter patent protecting the active substance of Feraccru.

Please use the link provided below for the full announcement.

US Composition of Matter Patent Press Release

Back to news

London, UK

One Euston Square
40 Melton Street
London, NW1 2FD

t+44 (0) 207 186 8500

einfo@shieldtx.com

Newcastle, UK

Northern Design Centre
Baltic Business Quarter
Gateshead Quays, NE8 3DF

t+44 (0) 191 511 8500

einfo@shieldtx.com

Wollerau, Switzerland

Sihleggstrasse 23,
8832 Wollerau
Switzerland

t+41 (0) 435 080 781

einfo@shieldtx.com

Munich, Germany

München 5 Höfe
Theatinerstrasse 11
DE- 80333 München

t+49 (0) 89 710 42 2246

einfo.de@shieldtx.com